In summary, the activation of Dectin-1 in TAMs and MDSCs, possibly mediated by the Syk-CARD9 pathway and influenced by the ligand galectin-9, leads to the generation of immunosuppressive cells and the formation of an immunosuppressive tumor microenvironment, inhibiting adaptive anti-tumor immunity and promoting tumor progression. This evidence concerns the gene CARD9 and neoplasm.